Medicine & Health Sciences
Get insights from 32.3k questions on Medicine & Health Sciences, answered by students, alumni, and experts. You may also ask and answer any question you like about Medicine & Health Sciences
Follow Ask QuestionQuestions
Discussions
Active Users
Followers
New answer posted
3 weeks agoScholar-Level 17
Hi.
A rank of 1000 in NEET PG places you in a strong but competitive position for MD General Medicine (often referred to as MS in Medicine colloquially) at Government Medical College (GMC), Nagpur.
Based on 2024 and 2025 cutoff data, your chances depend significantly on which quota and category you belong to:
1. All India Quota (AIQ) - 50%
Under AIQ, the competition is extremely tight for General Medicine at top-tier colleges like GMC Nagpur.
General Category: 2025 Round 2 Closing Rank: 997
2024 Round 2 Closing Rank: 537
Verdict: You are right on the borderline. While you might miss out in Round 1, you have a solid chance in Round 2 or
New answer posted
3 weeks agoScholar-Level 17
Hi.
Government Medical College Miraj – NEET PG 2025 Cutoffs
For the General category (Round 2) in 2025, the closing ranks for some courses were approximately:
MD/MS courses – General category
MD Radiodiagnosis: last around 1101
MD Dermatology, Venereology & Leprosy: 1037
MD Paediatrics: 6572
MD Obstetrics & Gynaecology: 6245
MS General Surgery: 6401
MS Orthopaedics: 9557
MD Anesthesiology: 19187
Other less competitive subjects closed even beyond 50,000+
New answer posted
3 weeks agoScholar-Level 17
Hi.
For the All India Category, the most branch is Radiodiagnosis, which typically closes within the top 150-350 ranks.
| Course | Closing Rank (2025) | Closing Rank (2024) |
| MD Radiodiagnosis | 347 | 135 |
| MD Nuclear Medicine | 526 | 2,026 |
| MD Anaesthesiology | 11,086 | 10,861 |
| MD Pathology | 23,964 | 29,071 |
| MD Microbiology | 47,639 | 42,348 |
New answer posted
3 weeks agoScholar-Level 17
Hi.
MD Radio-Diagnosis: Difficult for General/OBC in early rounds; keep an eye on Round 3/Stray Vacancy.
MD General Medicine: Very strong chance (you are right at the 2024 cutoff limit of ~748).
Other Clinical (Paeds, Surgery, ObGyn, Ortho): Guaranteed seat at MMC.
New answer posted
4 weeks agoScholar-Level 17
Hi.
5 % of seats (over and above the regular seat matrix) are reserved for:
Foreign nationals
OCI (Overseas Citizen of India) holders
PIO (Person of Indian Origin) candidates
These seats do not count against the general seats and are separate from the usual counselling pool.
New answer posted
4 weeks agoScholar-Level 17
Hi.
For the 2025 admission cycle, the *NIPER JEE exam was held on 10 June 2025.
This date applied to candidates seeking admission to M.S. (Pharm.) / M.Pharm. / MBA (Pharm.) / Ph.D. and other postgraduate programmes at all NIPER campuses including Ahmedabad.
Notification/registration opens around March–April 2026
Exam is likely to be in July 2026
Results would then follow in August–September 2026
based on projections and exam trends.
New answer posted
4 weeks agoScholar-Level 17
Hi.
Results
After the NIPER JEE exam (typically held in June), the results and merit lists for M.S. (Pharm.)/M.Pharm are usually released in late June.
For example, for the 2025 cycle, results and merit lists were published on 21 June 2025.
For the 2026 cycle, results are expected to be released a few weeks after the exam, following the same pattern (result dates are often announced on the official NIPER JEE site shortly after the exam).
Counselling
Counselling for MS Pharma/M.Pharm admissions usually occurs after the results are declared:
In the 2025 cycle, counselling was scheduled on 20–21 July 2025 based on rank lists.
These se
New answer posted
4 weeks agoScholar-Level 17
Hi.
Recent placement data show high placement percentages (often around or above 90 % for those who opt for placement) for postgraduate programmes, with a healthy median package in the range of several Lacs per annum.
Many students secure offers from core pharma companies through the campus drives orchestrated by the Placement Cell.
New answer posted
4 weeks agoScholar-Level 17
Hi.
Recent placement data show high placement percentages (often around or above 90 % for those who opt for placement) for postgraduate programmes, with a healthy median package in the range of several Lacs per annum.
Many students secure offers from core pharma companies through the campus drives orchestrated by the Placement Cell.
New answer posted
4 weeks agoScholar-Level 17
Hi.
Sun Pharma – Major Indian pharmaceutical manufacturer
Dr. Reddy's Laboratories – Global Indian pharma company
Lupin Pharmaceuticals – Large Indian generics player
Zydus Cadila / Cadila Pharma – Integrated healthcare company
Dabur – Ayurvedic & healthcare products company
Himalaya Herbals / Himalaya Drugs – Herbal healthcare & pharma
Laila Pharma – Pharmaceutical company
Mylan (now part of Viatris) – Global generics firm
Novartis – International pharma giant
Biocon – India's leading biotech & research company
Indegene Healthcare – Healthcare services & solutions provider
Matrix Laboratories / Coromandel International – P
Taking an Exam? Selecting a College?
Get authentic answers from experts, students and alumni that you won't find anywhere else
Sign Up on ShikshaOn Shiksha, get access to
- 66k Colleges
- 1.2k Exams
- 687k Reviews
- 1800k Answers
